A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies? - ScienceDirect
Antioxidants as Complementary Medication in Thalassemia | IntechOpen
2021 update on clinical trials in β‐thalassemia - Musallam - 2021 - American Journal of Hematology - Wiley Online Library
IJMS | Free Full-Text | Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
Safety and efficacy of thalidomide in patients with transfusion-dependent β- thalassemia: a randomized clinical trial | Signal Transduction and Targeted Therapy
Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley
Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine | Scientific Reports
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
Thalassaemia - The Lancet
Non-transfusion-dependent thalassemias | Haematologica
Sirolimus for Treatment of β-Thalassemia: From Pre-Clinical Studies to the Design of Clinical Trials
Full article: Revisiting beta thalassemia intermedia: past, present, and future prospects
Beta Thalassemia: Practice Essentials, Etiology, Epidemiology
Gene Therapy For Beta-Thalassemia: Updated Perspectives | TACG
Cureus | Improving Ineffective Erythropoiesis in Thalassemia: A Hope on the Horizon
Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation | SpringerLink
Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia
Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis
β-Thalassemia | Genetics in Medicine
New treatment strategies for β-thalassemia | Encyclopedia MDPI
Frontiers | The Future of Gene Therapy for Transfusion-Dependent Beta- Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells
Novel genetic therapeutic approaches for modulating the severity of β‑ thalassemia (Review)
Β-Thalassemias | NEJM
Pathophysiology and treatment of patients with... | F1000Research
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β- thalassemia | Haematologica
